MedKoo Cat#: 562475 | Name: OG-L002 HCl
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

OG-L002 HCl is an inhibitor of LSD1. OG-L002 disturbed fatty acid metabolism and induced lipid droplet accumulation through the impairment of lipophagy, but not bulk autophagy.

Chemical Structure

OG-L002 HCl
OG-L002 HCl
CAS#1357298-75-9

Theoretical Analysis

MedKoo Cat#: 562475

Name: OG-L002 HCl

CAS#: 1357298-75-9

Chemical Formula: C15H16ClNO

Exact Mass: 0.0000

Molecular Weight: 261.75

Elemental Analysis: C, 68.83; H, 6.16; Cl, 13.54; N, 5.35; O, 6.11

Price and Availability

Size Price Availability Quantity
5mg USD 500.00 2 Weeks
25mg USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
OG-L002 HCl; OG L002 HCl; OGL002 HCl; OG-L002 Hydrochloride; OG L002 Hydrochloride; OGL002 Hydrochloride;
IUPAC/Chemical Name
4-[(1R,2S)-2-Aminocyclopropyl]-[1,1-biphenyl]-3-ol Hydrochloride
InChi Key
VJDOOGRROQNQRV-DFQHDRSWSA-N
InChi Code
InChI=1S/C15H15NO.ClH/c16-14-9-13(14)12-7-6-11(8-15(12)17)10-4-2-1-3-5-10;/h1-8,13-14,17H,9,16H2;1H/t13-,14+;/m1./s1
SMILES Code
OC1=CC(C2=CC=CC=C2)=CC=C1[C@@H]3[C@@H](N)C3.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
OG-L002 HCl is an inhibitor of LSD1.
In vitro activity:
As shown in Fig. 2, compound OG-L002, which is highly specific to LSD1 (IC50, ~0.02 µM), potently inhibited the expression of viral IE (ICP27 and ICP4) genes, but not cellular control genes. As shown, OG-L002 inhibited viral IE gene expression in both cells with a significantly reduced IC50 (IC50, ~10 µM in HeLa cells; IC50, ~3 µM in HFF cells) relative to the control MAOI TCP (IC50, ~1 mM). In addition, OG-L002 potently reduced viral yields (~100-fold) in comparison to control DMSO treatment. Reference: mBio. 2013 Feb 5;4(1):e00558-12. https://pubmed.ncbi.nlm.nih.gov/23386436/
In vivo activity:
Here, this study analysed the activation by lipopolysaccaride (LPS) of primary splenocytes obtained from two different Ogg1-/- mouse strains. This study found that the induction of TNF-α expression was reduced in splenocytes (in particular macrophages) of both Ogg1-/- strains. Notably, an inhibitor of LSD1, OG-L002, reduced the induction of TNF-α mRNA in splenocytes from wild-type mice to the level observed in splenocytes from Ogg1-/- mice and had no influence in the latter cells. Reference: DNA Repair (Amst). 2017 Oct;58:13-20. https://pubmed.ncbi.nlm.nih.gov/28843610/

Preparing Stock Solutions

The following data is based on the product molecular weight 261.75 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Tallmadge RL, Žygelytė E, Van de Walle GR, Kristie TM, Felippe MJB. Effect of a Histone Demethylase Inhibitor on Equine Herpesvirus-1 Activity In Vitro. Front Vet Sci. 2018 Mar 12;5:34. doi: 10.3389/fvets.2018.00034. PMID: 29594155; PMCID: PMC5857540. 2. Liang Y, Quenelle D, Vogel JL, Mascaro C, Ortega A, Kristie TM. A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency. mBio. 2013 Feb 5;4(1):e00558-12. doi: 10.1128/mBio.00558-12. PMID: 23386436; PMCID: PMC3565832. 3. Seifermann M, Ulges A, Bopp T, Melcea S, Schäfer A, Oka S, Nakabeppu Y, Klungland A, Niehrs C, Epe B. Role of the DNA repair glycosylase OGG1 in the activation of murine splenocytes. DNA Repair (Amst). 2017 Oct;58:13-20. doi: 10.1016/j.dnarep.2017.08.005. Epub 2017 Aug 12. PMID: 28843610.
In vitro protocol:
1. Tallmadge RL, Žygelytė E, Van de Walle GR, Kristie TM, Felippe MJB. Effect of a Histone Demethylase Inhibitor on Equine Herpesvirus-1 Activity In Vitro. Front Vet Sci. 2018 Mar 12;5:34. doi: 10.3389/fvets.2018.00034. PMID: 29594155; PMCID: PMC5857540. 2. Liang Y, Quenelle D, Vogel JL, Mascaro C, Ortega A, Kristie TM. A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency. mBio. 2013 Feb 5;4(1):e00558-12. doi: 10.1128/mBio.00558-12. PMID: 23386436; PMCID: PMC3565832.
In vivo protocol:
1. Seifermann M, Ulges A, Bopp T, Melcea S, Schäfer A, Oka S, Nakabeppu Y, Klungland A, Niehrs C, Epe B. Role of the DNA repair glycosylase OGG1 in the activation of murine splenocytes. DNA Repair (Amst). 2017 Oct;58:13-20. doi: 10.1016/j.dnarep.2017.08.005. Epub 2017 Aug 12. PMID: 28843610.
1: Tallmadge RL, Žygelytė E, Van de Walle GR, Kristie TM, Felippe MJB. Effect of a Histone Demethylase Inhibitor on Equine Herpesvirus-1 Activity In Vitro. Front Vet Sci. 2018 Mar 12;5:34. doi: 10.3389/fvets.2018.00034. eCollection 2018. PubMed PMID: 29594155; PubMed Central PMCID: PMC5857540. 2: Seifermann M, Ulges A, Bopp T, Melcea S, Schäfer A, Oka S, Nakabeppu Y, Klungland A, Niehrs C, Epe B. Role of the DNA repair glycosylase OGG1 in the activation of murine splenocytes. DNA Repair (Amst). 2017 Oct;58:13-20. doi: 10.1016/j.dnarep.2017.08.005. Epub 2017 Aug 12. PubMed PMID: 28843610. 3: Aoki, S., Zhang, Z., Aoki, H., Umezawa, K., Kranrod, J., Miyazaki, N., ... & Ito, K. (2023). Effects of SP-2509 and OG-L002 on lipophagy using target or off-target molecules in glycolysis-suppressed pancreatic ductal adenocarcinoma cells.